Healthcare Triangle (HCTI) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChart

HCTI Stock Forecast


Healthcare Triangle stock forecast is as follows: a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

HCTI Analyst Ratings


Buy

According to 1 Wall Street analysts, Healthcare Triangle's rating consensus is 'Buy'. The analyst rating breakdown for HCTI stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Sep 28, 2022EF HuttonBuyBuyHold

Healthcare Triangle's last stock rating was published by EF Hutton on Sep 28, 2022. The company gave HCTI a "Buy" rating, the same as its previous rate.

Healthcare Triangle Financial Forecast


Healthcare Triangle Revenue Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Revenue---$7.78M$8.53M$9.84M$11.29M$11.95M$11.59M$11.06M
Avg Forecast$2.41M$2.98M$14.80M$14.50M$13.60M$12.90M$12.40M$12.60M$11.70M$10.40M
High Forecast$2.41M$2.98M$14.80M$14.50M$13.60M$12.90M$12.98M$12.60M$11.70M$10.40M
Low Forecast$2.41M$2.98M$14.80M$14.50M$13.60M$12.90M$11.82M$12.60M$11.70M$10.40M
# Analysts1111111111
Surprise %---0.54%0.63%0.76%0.91%0.95%0.99%1.06%

Healthcare Triangle's average Quarter revenue forecast for Dec 23 based on 1 analysts is $14.80M, with a low forecast of $14.80M, and a high forecast of $14.80M. HCTI's average Quarter revenue forecast represents a 90.26% increase compared to the company's last Quarter revenue of $7.78M (Sep 23).

Healthcare Triangle EBITDA Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
EBITDA---$-812.00K$-1.18M$-2.33M$-3.85M$-1.34M$-589.00K$-1.26M
Avg Forecast$-104.67K$-129.44K$-641.98K$-628.96K$-589.92K$-559.56K$-537.87K$-606.83K$-563.48K$-1.26M
High Forecast$-104.67K$-129.44K$-641.98K$-628.96K$-589.92K$-559.56K$-512.72K$-606.83K$-563.48K$-1.01M
Low Forecast$-104.67K$-129.44K$-641.98K$-628.96K$-589.92K$-559.56K$-563.03K$-606.83K$-563.48K$-1.52M
Surprise %---1.29%1.99%4.17%7.16%2.20%1.05%1.00%

undefined analysts predict HCTI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Healthcare Triangle's previous annual EBITDA (undefined) of $NaN.

Healthcare Triangle Net Income Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
Net Income---$-1.94M$-1.79M$-3.28M$-4.86M$-2.34M$-405.00K$-2.01M
Avg Forecast$8.73M$7.14M$-1.13M$-1.70M$-1.70M$-2.27M$-2.27M$-2.13M$-2.66M$-2.01M
High Forecast$8.73M$7.14M$-1.13M$-1.70M$-1.70M$-2.27M$-2.27M$-2.13M$-2.66M$-1.61M
Low Forecast$8.73M$7.14M$-1.13M$-1.70M$-1.70M$-2.27M$-2.27M$-2.13M$-2.66M$-2.41M
Surprise %---1.14%1.05%1.45%2.15%1.10%0.15%1.00%

Healthcare Triangle's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. HCTI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Healthcare Triangle SG&A Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
SG&A---$2.46M$2.64M$3.39M$2.90M$3.29M$3.10M$3.09M
Avg Forecast$517.88K$640.42K$3.18M$3.11M$2.92M$2.77M$2.66M$2.70M$2.51M$3.09M
High Forecast$517.88K$640.42K$3.18M$3.11M$2.92M$2.77M$2.79M$2.70M$2.51M$3.71M
Low Forecast$517.88K$640.42K$3.18M$3.11M$2.92M$2.77M$2.54M$2.70M$2.51M$2.47M
Surprise %---0.79%0.90%1.22%1.09%1.22%1.24%1.00%

Healthcare Triangle's average Quarter SG&A projection for Dec 23 is $3.18M, based on 1 Wall Street analysts, with a range of $3.18M to $3.18M. The forecast indicates a 28.86% rise compared to HCTI last annual SG&A of $2.46M (Sep 23).

Healthcare Triangle EPS Forecast

Sep 24Jun 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
# Analysts1111111111
EPS---$-0.46$-0.00$-0.08$-0.13$-0.06$-0.01$-0.06
Avg Forecast$1.54$1.34$-0.20$-0.30$-0.30$-0.40$-0.40$-0.40$-0.50$-0.50
High Forecast$1.54$1.34$-0.20$-0.30$-0.30$-0.40$-0.40$-0.40$-0.50$-0.50
Low Forecast$1.54$1.34$-0.20$-0.30$-0.30$-0.40$-0.40$-0.40$-0.50$-0.50
Surprise %---1.53%0.00%0.20%0.33%0.16%0.02%0.11%

According to undefined Wall Street analysts, Healthcare Triangle's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HCTI previous annual EPS of $NaN (undefined).

Healthcare Triangle Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
CMAXCareMax$0.42$2.20423.81%Hold
HCTIHealthcare Triangle$0.88$2.00127.27%Buy
MPLNMultiPlan$7.07$10.0041.44%Hold

HCTI Forecast FAQ


Is Healthcare Triangle a good buy?

Yes, according to 1 Wall Street analysts, Healthcare Triangle (HCTI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of HCTI's total ratings.

Did the HCTI's actual financial results beat the analysts' financial forecasts?

Based on Healthcare Triangle's last annual report (Dec 2023), the company's revenue was $33.2M, which missed the average analysts forecast of $55.8M by -40.50%. Apple's EBITDA was $-6.11M, beating the average prediction of $-2.42M by 152.43%. The company's net income was $-12.339M, beating the average estimation of $-6.799M by 81.47%. Apple's SG&A was $10.09M, missing the average forecast of $11.98M by -15.71%. Lastly, the company's EPS was $-0.0029, missing the average prediction of $-1.2 by -99.76%. In terms of the last quarterly report (Sep 2023), Healthcare Triangle's revenue was $7.78M, missing the average analysts' forecast of $14.5M by -46.35%. The company's EBITDA was $-812K, beating the average prediction of $-629K by 29.10%. Healthcare Triangle's net income was $-1.943M, beating the average estimation of $-1.7M by 14.30%. The company's SG&A was $2.46M, missing the average forecast of $3.11M by -20.79%. Lastly, the company's EPS was $-0.46, beating the average prediction of $-0.3 by 53.33%